Home
News
News archive
Diamond Information


home > news Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says

Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says




The US Food and Drug Administration warns that prescription weight loss medicine Belviq might be associated with an increased risk of cancer.



Click Here to read the entire article...



Find this article in Google